Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited on October 12, 2026, confirming compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026. The certificate, dated October 3, 2026, was received from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, the company's Registrar and Share Transfer Agent.

Sanofi Consumer Healthcare India Limited will close its trading window from October 1, 2026, until 48 hours after the announcement of its unaudited standalone financial results for the quarter and nine months ended September 30, 2026, according to a filing with the BSE Limited and National Stock Exchange of India Limited.

Net profit of Sanofi Consumer Healthcare India rose 13.34% to Rs 68.80 crore in the quarter ended June 2026 as against Rs 60.70 crore during the previous quarter ended June 2025. Sales rose 6.70% to Rs 235.70 crore in the quarter ended June 2026 as against Rs 220.90 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales235.70220.90 7 OPM %37.8931.78 - PBDT95.2075.30 26 PBT91.9072.30 27 NP68.8060.70 13 Powered by Capital Market - Live

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 28 July 2026.

Sanofi Consumer Healthcare India announced that the Annual General Meeting(AGM) of the company will be held on 26 June 2026.

Net profit of Sanofi Consumer Healthcare India rose 35.60% to Rs 67.80 crore in the quarter ended March 2026 as against Rs 50.00 crore during the previous quarter ended March 2025. Sales rose 32.79% to Rs 229.20 crore in the quarter ended March 2026 as against Rs 172.60 crore during the previous quarter ended March 2025. ParticularsQuarter EndedMar. 2026Mar. 2025% Var. Sales229.20172.60 33 OPM %38.7437.08 - PBDT93.9068.80 36 PBT90.7066.80 36 NP67.8050.00 36 Powered by Capital Market - Live

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 28 April 2026.

Tejas Networks Ltd, KSB Ltd, Balu Forge Industries Ltd and SpiceJet Ltd are among the other gainers in the BSE's 'A' group today, 26 February 2026.Sanofi Consumer Healthcare India Ltd soared 15.09% to Rs 4610.15 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 51089 shares were traded on the counter so far as against the average daily volumes of 1121 shares in the past one month. Tejas Networks Ltd spiked 12.13% to Rs 356.45. The stock was the second biggest gainer in 'A' group. On the BSE, 24.86 lakh shares were traded on the counter so far as against the average daily volumes of 2.69 lakh shares in the past one month. KSB Ltd surged 10.42% to Rs 793.3. The stock was the third biggest gainer in 'A' group. On the BSE, 6.03 lakh shares were traded on the counter so far as against the average daily volumes of 3939 shares in the past one month. Balu Forge Industries Ltd exploded 10.00% to Rs 490.75. The stock was the fourth biggest gainer in 'A' group. On the BSE, 1.93 lakh shares were traded on the counter so far as against the average daily volumes of 1.1 lakh shares in the past one month. SpiceJet Ltd advanced 8.63% to Rs 15.73. The stock was the fifth biggest gainer in 'A' group. On the BSE, 432.79 lakh shares were traded on the counter so far as against the average daily volumes of 276.35 lakh shares in the past one month. Powered by Capital Market - Live

Sanofi Consumer Healthcare India announced that the Board of Directors of the Company at its meeting held on 25 February 2026, inter alia, have recommended the final dividend of Rs 75 per equity Share (i.e. 750%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Sanofi Consumer Healthcare India rose 50.11% to Rs 66.50 crore in the quarter ended December 2025 as against Rs 44.30 crore during the previous quarter ended December 2024. Sales rose 47.04% to Rs 251.00 crore in the quarter ended December 2025 as against Rs 170.70 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales251.00170.70 47 OPM %35.7836.38 - PBDT93.9066.70 41 PBT90.5065.70 38 NP66.5044.30 50 Powered by Capital Market - Live